A Randomized, Adaptive, Double-Blind, Placebo-Controlled, Operationally Seamless Phase 2/3 Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of AIC263029 in the Treatment of BKV Infection in Kidney Transplant Recipients
Latest Information Update: 09 Apr 2026
At a glance
- Drugs AIC 468 (Primary)
- Indications Polyomavirus infections
- Focus Adverse reactions
- Sponsors AiCuris
Most Recent Events
- 09 Apr 2026 New trial record